NASDAQ · Healthcare · Drug Manufacturers - General
Market Cap$176.11B
SectorHealthcare
Industry
Drug Manufacturers - General
52-Week Low$267.83
52-Week High$391.29
CEORobert A. Bradway
IPO DateJun 17, 1983
Employees28,000
CountryUnited States
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas.